UNITED STATES

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

Mark One

x ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended August 31, 2017February 28, 2018

¨ ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________ to ______________

Commission File No. Number:333-194055

KANGE CORP.

(Exact name of registrant as specified in its charter)

Nevada		7371		33-1230169
(State or Other Jurisdictionother jurisdiction of Incorporation or Organization) incorporation)		(Primary Standard Industrial Classification Number)		(IRS Employer Identification Number)

11724 Ventura Blvd Suite B,

Studio City, California 91604

(818) 853-7033

(Address and telephone number of principal executive offices)

(818) 853-7033

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the Registrantregistrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrantregistrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes   o ☒ No x

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes  x ☐ No o

Indicate by check mark whether the Registrantregistrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smallersmaller reporting company" in Rule 12b-2 of the Exchange Act.

(Check one):

Large accelerated filer	o☐	Accelerated filer	o☐
Non-accelerated filer	o☒	Smaller reporting company	x☒
		(Do not check if a smaller reporting company)Emerging growth company		☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the Registrantregistrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes  o ☒ No x

As of October 23, 2017 there were 13,948,700May 7, 2021, the Company had 14,553,465 shares of common stock par value $0.001 per share outstanding.

KANGE CORP.

INDEX

		Page
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS				12
PART I. FINANCIAL INFORMATION				3
Item 1.	Financial Statements			4F-1
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations			123
Item 3.	Quantitative and Qualitative and Quantitative Disclosures Aboutabout Market RiskRisks			158
Item 4.	Controls and Procedures			158
PART II. OTHER INFORMATION				179
Item 1.	Legal Proceedings			179
Item 1A.	Risk Factors			9
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds			179
Item 3.	Defaults Upon Senior Securities			179
Item 4.	Mine Safety DisclosureDisclosures			179
Item 5.	Other informationInformation			179
Item 6.	Exhibits			18 9
SIGNATURES				1910

2

PART I – FINANCIAL INFORMATION

Kange Corp.

TABLE OF CONTENTS

Index to Financial Statements   Page   Condensed Balance Sheets as of August 31, 2017at February 28, 2018 and November 30, 20162017 (unaudited)   4F-2   Condensed Statements of Operations for the three and nine months ended August 31,February 28, 2018 and 2017 (unaudited)   5F-3   Condensed Statement of Changes in Stockholders’ Equity (Deficit) for the three months ended February 28, 2018 and 2017 (unaudited) F-4 Statements of Cash Flows for the ninethree months ended August 31,February 28, 2018 and 2017 and 2016 (unaudited)   6F-5   Notes to Unaudited Condensed Financial Statements (unaudited)   7F-6     3F-1 Table of Contents Item 1. Financial Statements KANGE CORP. CONDENSED BALANCE SHEETS (Unaudited) Kange Corp Balance Sheets (Unaudited)       August 31,     November 30,       2017     2016                 ASSETS Current assets             Cash   $ 77     $ 155   Total current assets     77       155                     Total Assets   $ 77     $ 155                     LIABILITIES AND STOCKHOLDERS' DEFICIT                   Current liabilities                 Convertible notes payable to related parties, net of discount   $ 54,251     $ 52,081   Accounts payable     -       200   Due to related party     21,919       10,250   Accrued expenses     5,082       -   Accrued expenses - related party     10,925       6,029   Total current liabilities     92,177       68,560                     Total Liabilities     92,177       68,560                     Stockholders' deficit                 Common stock, $0.001 par value, 75,000,000 shares authorized,                 10,665,000 and 10,570,000 shares issued and outstanding, respectively     10,665       10,570   Additional paid-in capital     617,158       541,253   Accumulated deficit     (719,923 )     (620,228 ) Total stockholders' deficit     (92,100 )     (68,405 )                   Total liabilities and stockholders' deficit   $ 77     $ 155         As of       As of         February 28,       November 30,         2018       2017   ASSETS                 Current Assets                 Cash and cash equivalents   $ 0     $ 77   Marketable securities     113,863       81,000   Prepaid expenses     45,600       66,312   Total Current Assets     159,463       147,389   TOTAL ASSETS   $ 159,463     $ 147,389                     LIABILITIES AND STOCKHOLDERS' EQUITY                 Current Liabilities                 Accounts payable and accrued liabilities   $ 9,611     $ 5,250   Accrued expenses - related party     4,000       1,000   Due to related parties     28,151       26,901   Total Current Liabilities     41,762       33,151                     Stockholders' Equity                 Common stock, $0.001 par value, 750,000,000 shares authorized, 14,165,842 shares issued and outstanding.     14,166       14,166   Additional paid-in capital     808,332       808,332   Accumulated deficit     (704,797 )     (708,260 ) Total Stockholders' Equity     117,701       114,238                     TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY   $ 159,463     $ 147,389     SeeThe accompanying notes to condensedare an integral part of these unaudited financial statements.   4F-2 Table of Contents KANGE CORP. CONDENSED STATEMENTS OF OPERATIONS (Unaudited) Kange Corp Statements of Operations       Three Months Ended         February 28,         2018       2017                     Revenues   $ 0     $ 0   Operating Expenses                 General and administrative     8,688       8,009   Consulting     20,712       0   Total operating expenses     29,400       8,009   Operating loss     (29,400 )     (8,009 )                   Other income (expense)                 Interest expense     0       (1,627 ) Amortization of debt discounts     0       (1,550 ) Unrealized gain on marketable securities     32,863       0   Total other expenses     32,863       (3,177 ) Net income (loss) before income taxes     3,463       (11,186 ) Provision for income taxes     0       0   Net income (loss)   $ 3,463     $ (11,186 ) Basic and diluted income (loss) per common share   $ 0.00     $ (0.00 ) Basic and diluted weighted average common shares outstanding     14,167,524       10,570,000         For the Three Months Ended     For the Nine Months       August 31,     August 31,       2017     2016     2017     2016   Revenue   $ -     $ -     $ -     $ -                                     Operating expenses:                                 General and administrative     2,049       6,140       16,629       23,503   Consulting     76,000       -       76,000       -   Total Operating Expenses     78,049       6,140       92,629       23,503                                     Operating loss     (78,049 )     (6,140 )     (92,629 )     (23,503 )                                   Other income (expense):                                 Interest expense     (1,642 )     (1,628 )     (4,896 )     (4,198 ) Amortization of debt discounts     -       (15,348 )     (2,170 )     (42,366 ) Total other income (expense)     (1,642 )     (16,976 )     (7,066 )     (46,564 )                                   Net loss   $ (79,691 )   $ (23,116 )   $ (99,695 )   $ (70,067 )                                   Net Income/(loss) per share - basic and diluted   $ (0.01 )   $ (0.00 )     (0.01 )     (0.01 )                                   Weighted average number of shares outstanding - basic and diluted     10,576,196       10,570,000       10,572,080       10,570,000   SeeThe accompanying notes to condensedare an integral part of these unaudited financial statements.   5F-3 Table of Contents   Table of Contents Kange Corp Statement of Changes in Stockholders' Equity (Deficit) (Unaudited)   KANGE CORP. CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) For the Three Months Ended February 28, 2018                         Additional                         Common Stock       Paid in       Accumulated                 Shares       Amount       Capital       Deficit       Total   Balance - November 30, 2017     14,165,842     $ 14,166     $ 808,332     $ (708,260 )   $ 114,238   Net income for the period     0       0       0       3,463       3,463   Balance - February 28, 2018     14,165,842     $ 14,166     $ 808,332     $ (704,797 )   $ 117,701       For the Nine Months Ended       August 31,       2017     2016   Cash flows from operating activities:             Net Income/(loss)   $ (99,695 )   $ (70,067 ) Adjustments to reconcile net loss to net cash (used in) operating activities:                 Amortization of debt discount     2,170       42,366   Issuance of common stock for services     76,000       -   Changes in operating assets and liabilities                 Accounts payable     (200 )     (5,632 ) Accrued expenses     5,082       -   Accrued expenses to related party     4,896       897   Net cash used in operating activities     (11,747 )     (32,436 )                   Cash flows from financing activities:                 Proceeds from loan from related party     11,669       6,250   Proceeds from convertible note payable to relate party     -       26,188   Net cash provided by financing activities     11,669       32,438                     Net Change in Cash     (78 )     2                     Cash, beginning of period     155       243                     Cash, end of period   $ 77     $ 245                                       SUPPLEMENTARY DISCLOSURE OF CASH FLOW INFORMATION:                                   Cash paid for interest   $ -     $ -   Cash paid for taxes   $ -     $ -   For the Three Months Ended February 28, 2017                         Additional                         Common Stock       Paid in       Accumulated                  Shares        Amount        Capital        Deficit        Total   Balance - November 30, 2016     10,570,000     $ 10,570     $ 541,253     $ (620,228 )   $ (68,405 ) Net loss for the period     0       0       0       (11,186 )     (11,186 ) Balance - February 28, 2017     10,570,000     $ 10,570     $ 541,253     $ (631,414 )   $ (79,591 ) See The accompanying notes to condensedare an integral part of these unaudited financial statements.   6F-4 Table of Contents   Kange Corp Statements of Cash Flows (Unaudited)       Three Months Ended         February 28,         2018       2017                     CASH FLOWS FROM OPERATING ACTIVITIES                 Net income (loss)   $ 3,463     $ (11,186 ) Adjustments to reconcile net loss to net cash used in operating activities:                 Amortization of debt discount     0       1,550   Unrealized gain on marketable securities     (32,863 )     0   Changes in operating assets and liabilities:                 Prepaid expenses     20,712       0   Accounts payable and accrued liabilities     4,361       7,919   Accrued expenses to related party     3,000       1,627   Net cash used in operating activities     (1,327 )     (90 )                   CASH FLOWS FROM FINANCING ACTIVITIES                 Proceeds from loan from related party     1,250       0   Net cash provided by financing activities     1,250       0                     Net change in cash for the period     (77 )     (90 ) Cash at beginning of period     77       155   Cash at end of period   $ 0     $ 65                     SUPPLEMENTAL CASH FLOW INFORMATION:                 Cash paid for income taxes   $ 0     $ 0   Cash paid for interest   $ 0     $ 0   The accompanying notes are an integral part of these unaudited financial statements. F-5 Table of Contents KANGE CORP. NOTES TO THE CONDENSED FINANCIAL STATEMENTS AUGUST 31, 2017 (Unaudited) FEBRUARY 28, 2018 NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS Organization Kange Corp. ("Kange," the "Company," "we," "us," or "our") was incorporated under the laws of the State of Nevada on August 16, 2013 (Inception). We are a development stagestart up company developing mobile software products, for Apple and Android platforms, starting in Estonia and Europe, which is our initial intended market. Apple is a trademark of Apple Inc., and Android is a trademark of Alphabet Inc. During 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments, we retained an advisor having substantial experience in the technology sector, we retained two former professional athletes to advise us regarding sports health issues and treatments, and we intend to provide services  to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. The Company is currently evaluating future operations in the wholistic health industry. Basis of Presentation The accompanying unaudited condensed financial statements of Kange Corp.the Company are condensed and have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”), including the instructions to Form 10-Q and Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles for interim financialin the United States of America (“U.S. GAAP”), have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and the instructions to Form 10-Q and Article 8 of Regulation S-X. The results of operations for the interim period ended August 31, 2017 shown in this report are not necessarily indicative of results to be expected for the full fiscal year ending November 30, 2017. In the opinion of the Company's management, the information contained herein reflects all adjustments (consisting of normal recurring adjustments)notes necessary for a fair presentation of the Company's results of operations,comprehensive financial positionstatements and cash flows. The unaudited interim condensed financial statements should be read in conjunction with theour audited consolidated financial statements included in the Company'sour Annual Report on Form 10-K for the year ended November 30, 2016 filed on March 3, 2017 and Management's Discussion and Analysis2017. The results of Financial Condition and Resultsoperations for the period ended February 28, 2018 are not necessarily indicative of Operations. the operating results for the full year. Fair Value of Financial Instruments The Company measures its financial assets and liabilities in accordance with generally accepted accounting principles. For certain of our financial instruments, including cash, accounts payable, accrued expenses, and short-term loans the carrying amounts approximate fair value due to their short maturities. The Company evaluates its convertible debt, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. The result of this accounting treatment is that under certain circumstances the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under this accounting standard are reclassified to liability at the fair value of the instrument on the reclassification date. 7 Table of Contents KANGE CORP. NOTES TO THE CONDENSED FINANCIAL STATEMENTS AUGUST 31, 2017 (Unaudited) Going Concern The accompanying unaudited condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company sustained net losses of $99,695 and used cash in operating activities of $11,747$1,327 for the nine monthsperiod ended August 31, 2017.February 28, 2018. The Company had working capital deficit, stockholders' deficit andan accumulated deficit of $92,100, $92,100 and $719,923, respectively,$704,797, at August 31, 2017.February 28, 2018. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital and loans from thirdrelated parties to sustain its current level of operations. The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships. No assurance can be given that the Company will be successful in these efforts. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statementsstatements. The estimates and judgments will also affect the reported amounts of revenues andfor certain expenses during the reporting period. Actual results could differ from those estimates. Significantthese good faith estimates in the accompanying financial statements include the amortization period for intangible assets, valuation and impairment valuation of intangible assets, depreciable lives of the web site and property and equipment, valuation of warrants and beneficial conversion feature debt discounts, valuation of derivatives, valuation of share-based payments and the valuation allowance on deferred tax assets. Reclassifications Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported losses, total assets, or stockholders' equity as previously reported. judgments. F-6 Table of Contents Net Earnings (Loss) Per Share In accordance with ASC 260-10, "Earnings per Share," basic net earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. Dilutive common stock equivalent sharesperiod, which may dilute future earnings per share consist of convertible notes convertible into 2,851,185 common shares. Equivalent shares are not utilized whenexcluded from the effect is anti-dilutive (see Note 3). 8 Table of Contents KANGE CORP. NOTES TO THE CONDENSED FINANCIAL STATEMENTS AUGUST 31, 2017 (Unaudited) computation if anti-dilutive.  There are no dilutive or potentially dilutive securities outstanding during the periods presented. Effect of Recent Accounting Pronouncements The Company reviews new accounting pronouncements as issued. NoExcept as disclosed in Note 2, no new pronouncements had any material effect on these unaudited financial statements. The accounting pronouncements issued subsequent to the date of these unaudited financial statements that were considered significant by management were evaluated for the potential effect on these unaudited financial statements. Management does not believe any of the subsequent pronouncements will have a material effect on these unaudited financial statements as presented and does not anticipate the need for any future restatement of these unaudited condensed financial statements because of the retro-active application of any accounting pronouncements issued subsequent to August 31, 2017February 28, 2018 through the date these unaudited financial statements were issued. Reclassifications Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported losses, total assets, or stockholders' equity as previously reported.   NOTE 2 – ASSIGNMENT OF CONTRACTUAL RIGHTSMARKETABLE SECURITIES   We adopted ASU 2016-01 on December 1, 2017, which requires us to measure all equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in earnings. We use quoted market prices to determine the fair value of equity securities with readily determinable fair values. On November 9, 2015, in exchange for 5,000,0001, 2017 the Company executed a stock purchase agreement (the “SPA”) with AMJ Global Entertainment, LLC, a related party and holder of 4,803,195 shares of common stock ofin Patient Access Solutions Inc., a Nevada corporation with ticker symbol “PASO”. Pursuant to the SPA, the Company the Company was assigned by AMJ Global, LLC ("AMJ Global"), a company beneficially owned by Dr. Arthur Malone, Jr., the Company's chief executive officer and director, the contractual rightsissued 158,824 shares of AMJ Global pursuant to its agreements with Blabeey, Inc. ("Blabeey"), a mobile App designer focused on social media and messaging. The irrevocable assignment, transferred and conveyed in its entirety to the Company, all of AMJ Global's rights and obligations that are stipulated and set forth in every and all agreements between AMJ Global and Blabeey, including, but not limited to, the agreement between AMJ Global and Blabeey dated October 26, 2015. The transaction was, due to the structure of the agreement, between entities under common control and therefore the amount of the historical cost of the assets, $471,672, was recorded as an expense as there is no fixed and determinable future value, and the expense was recorded as a loss on the acquisition of contractual rights. See Notes 5 and 6. NOTE 3 – CONVERTIBLE NOTES PAYABLE TO RELATED PARTIES, NET OF DISCOUNTS Convertible notes payable, net of discounts, all classified as current at August 31, 2017 and November 30, 2016, consists of the following: Convertible notes to related parties, net of discounts     August 31, 2017 November 30, 2016               Principal,             Principal,           Debt     net of         Debt     net of       Principal     Discount     Discounts     Principal     Discount     Discounts                                         AMJ Global, LLC (a)   $ 9,935     $ -     $ 9,935     $ 9,935     $ -     $ 9,935   AMJ Global, LLC     18,128       -       18,128       18,128       -       18,128   AMJ Global, LLC     19,901       -       19,901       19,901       -       19,901   AMJ Global, LLC     6,287       -       6,287       6,287       (2,170 )     4,117                                                     Total   $ 54,251     $ -     $ 54,251     $ 54,251     $ (2,170 )   $ 52,081   _________ (a) Assigned from Victor Stepanov on March 15, 2016. On November 9, 2015, the Company executed a convertible promissory note with Victor Stepanov, the former chief executive officer and director of the Company, for $9,935,stock in exchange for accrued compensation pursuant to his employment agreement with1,157,142 shares of Patient Access Solutions Inc.  On November 1, 2018, the Company. The note bears interestCompany recorded the shares of Patient Access Solutions Inc. at the rate of 12% per annum, which accrues monthly.$81,000. As of August 31, 2017 and November 30, 2016,February 28, 2018, based quoted market prices, the accrued interest was $2,162 and $1,265, respectively. The note matured on November 8, 2016. The note has a conversion featureCompany recognized an unrealized gain of $0.02 per share. A beneficial conversion feature of $9,935 was recorded and was accreted monthly from the issuance date of the note through maturity. As of August 31, 2017 and November 30, 2016, $9,935 and $9,935, respectively, has been recorded as a beneficial conversion feature expense. On March 15, 2016, Mr. Stepanov assigned this convertible promissory note to AMJ Global, LLC ("AMJ Global"). See Notes 5 and 6.$32,863.   9 Table of Contents The carrying values of our equity securities were included in the following line items in our balance sheets:   KANGE CORP. NOTES TO THE CONDENSED FINANCIAL STATEMENTS AUGUST 31, 2017 (Unaudited) Equity securities at November 30, 2017   $ 81,000   Addition of equity securities     0   Net unrealized gain recognized during the period related to equity securities still held at the end of the period     32,863   Equity securities at February 28, 2018   $ 113,863     On November 9, 2015, the Company executed a convertible promissory note with AMJ Global, a company which is beneficially owned by Dr. Arthur Malone, Jr., the chief executive officer and director of the Company, for $18,128. This note was created due to the assignment of the balance due to shareholder (see Note 5), which was assigned to AMJ Global on November 9, 2015. The note bears interest at the rate of 12% per annum, which accrues monthly. As of August 31, 2017 and November 30, 2016, the accrued interest was $3,946 and $2,310, respectively. The note matured on November 8, 2016. The note has a conversion feature of $0.02 per share. A beneficial conversion feature of $18,128 was recorded and was accreted monthly from the issuance date of the note through maturity. As of August 31, 2017 and November 30, 2016, $18,128, respectively, has been recorded as a beneficial conversion feature expense. See Note 5. On February 5, 2016, the Company executed a convertible promissory note with AMJ Global for $19,901. This note was in exchange for the payment of certain vendors of the Company. The note bears interest at the rate of 12% per annum, which accrues monthly. As of August 31, 2017 and November 30, 2016, the accrued interest was $3,756 and $1,960. The note matured on February 4, 2017. The note has a conversion feature of $0.02 per share. A beneficial conversion feature of $19,901 was recorded and was accreted monthly from the issuance date of the note through maturity. As of August 31, 2017, $19,901 has been recorded as a beneficial conversion feature expense. See Note 5. On April 6, 2016, the Company executed a convertible promissory note with AMJ Global for $6,287. This note was in exchange for the payment of certain vendors of the Company. The note bears interest at the rate of 12% per annum, which accrued monthly. As of August 31, 2017 and November 30, 2016, the accrued interest was $1,061 and $493. The note matured on April 6, 2017. The note has a conversion feature of $0.02 per share. A beneficial conversion feature of $6,287 was recorded and was accreted monthly from the issuance date of the note through maturity. As of August 31, 2017, $6,287 has been recorded as a beneficial conversion feature expense. See Note 5. NOTE 4 – COMMITMENTS AND CONTINGENCIES Legal Matters From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of August 31, 2017, there were no pending or threatened lawsuits. NOTE 53 – RELATED PARTY TRANSACTIONS   In support of the Company's efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are considered temporary in nature and have not been formalized by a promissory note.   On August 16, 2013, our sole director and principal shareholder advanced $678 to the Company to fund its initial incorporation with the Nevada Secretary of State. The sole director and principal shareholder loaned a further $500 to the Company on October 30, 2013 as working capital. During October 2014, a director had loaned $10,300 to the Company for working capital. During the fiscal year 2015, through November 9, 2015, an additional $6,650 was loaned to the Company. On November 9, 2015, the total for the loan from this director was $18,128 and it was assigned to AMJ Global, a company controlled by Dr. Arthur Malone, Jr., the Company's chief executive officer and director. The Company executed a convertible note payable to AMJ Global for $18,128. This note was created due to the assignment of the balance due to shareholder (see Note 3), which was assigned to AMJ Global on November 9, 2015. F-7 10 Table of Contents   KANGE CORP. NOTES TO THE CONDENSED FINANCIAL STATEMENTS AUGUST 31,On November 1, 2017, (Unaudited) On February 5, 2016, the Company executedentered into a convertible promissory noteone-year office lease agreement with AMJ Global for $19,901. This note was in exchange forEntertainment LLC, a related party controlled by the payment of certain vendorsCompany’s CEO and director, ending November 2, 2018. The location of the Company.leased office space is 11724 Ventura Blvd Suite B, Studio City, California 91604. The note bears interest atlease states monthly rent due of $1,000. During the rate of 12% per annum, which accrues monthly. The note matured on June 8, 2016. The note has a conversion feature of $0.02 per share. See Note 3. On March 15, 2016, Mr. Stepanov assigned his convertible promissory note to AMJ Global. See Note 3.  On April 6, 2016,three months ended February 28, 2018, the Company executed a convertible promissory note with AMJ Global for $6,287. This note was in exchange for the paymentaccrued $3,000 due to related party. As of certain vendors of the Company. The note bears interest at the rate of 12% per annum, which accrued monthly. The note matured on April 6, 2017. The note has a conversion feature of $0.02 per share. See Note 3. In the nine months ended August 31,February 28, 2018 and November 30, 2017, the Company had $11,669 of general and administrative expenses paid by AMJ Global, a company beneficially owned by Dr. Arthur Malone, Jr., the chief executive officer and director of the Company. As of August 31, 2017 and November 30, 2016, the Company had accrued expenses to related party balances of $10,925 and $6,029 as well as ahas recorded lease expense due to related party balance of $21,919$4,000 and 10,250.$1,000, respectively. NOTE 4 – COMMON STOCK   NOTE 6 – STOCKHOLDERS' DEFICITCommon Stock   Common Stock TheOn November 27, 2017, the Company wasincreased its authorized to issue up to 75,000,000 shares of common stock from 75,000,000 to 750,000,000, par value $0.001 per share. Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive rights.   InDuring the nine monthsyear ended August 31,November 30, 2017, the Company issued 95,000a total of 155,000 shares of common stock to fourfive separate consultants pursuant to four advisory board agreements. Three advisory board agreements were made effective on May 25, 2017 with terms of 15,000 shares each to be issued for one year of services to be rendered. Two advisory board agreements were made effective on October 1, 2017 with terms of 30,000 shares each to be issued for one year of services. The Company valued the advisory agreements shares issued to consultants at based on the closing stock price of the Company on the date of the executed agreement which resulted in a total combined value of $124,000 initially recorded as prepaid expense to be amortized ratably over the contract term. During the three months ended February 28, 2018, the Company recording arecorded consulting expense in the amount of $76,000. $20,712 resulting in the remaining balance of prepaid expense, the uncompleted portion of the contract, of $45,600 and $66,312 at February 28, 2018 and November 30, 2017, respectively. There were 10,665,00014,167,524 shares of common stock issued and outstanding as of August 31, 2017.February 28, 2018 and November 30, 2017. NOTE 5 – SUBSEQUENT EVENTS   NOTE 7 – SUBSEQUENT EVENTSOn January 13, 2020, the transaction was rescinded, and the Company will return 1,157,142 shares of Patient Access Solutions Inc. back to AMJ Global Entertainment, LLC in exchange for 157,142 shares of the Company.   ManagementOn March 5, 2018, the Company issued 387,623 shares of common stock to settled debt of $32,151 to a related party. The Company has evaluated subsequent events pursuantoccurring subsequent to the requirements of ASC Topic 855balance sheet date through the date these financial statements were issued, and has determined that other than listed below,there are no material subsequentadditional events exist.requiring disclosure. 1. In September of 2017, the Company issued 3,283,700 shares of common stock to a related party for the conversion of outstanding debt.   11F-8 Table of Contents   Table of Contents ITEMItem 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION SPECIAL NOTE CONCERNING FORWARD-LOOKING STATEMENTS We believe that it is important to communicate our future expectations to our security holders and to the public. This report, therefore, contains statements about future events and expectations which are "forward-looking statements" within the meaning of Sections 27A of the Securities Act of 1933 and 21E of the Securities Exchange Act of 1934, including the statements about our plans, objectives, expectations and prospects under the heading "Management'sManagement's Discussion and Analysis of Financial Condition and Results of Operations." You can expect to identify theseOperations This Quarterly Report on Form 10-Q contains forward-looking statements by forward-looking words suchwithin the meaning of Rule 175 of the Securities Act of 1933, as "may," "might," "could," "would," "will," "anticipate," "believe," "plan," "estimate," "project," "expect," "intend," "seek"amended, and other similar expressions. Any statement contained in this reportRule 3b-6 of the Securities Act of 1934, as amended, that is not a statement of historical fact may be deemed to be a forward-looking statement. Although we believe that the plans, objectives, expectationsinvolve substantial risks and prospects reflected in or suggested by ouruncertainties. These forward-looking statements are reasonable, thosenot historical facts, but rather are based on current expectations, estimates and projections about our industry, our beliefs and our assumptions. Words such as “anticipate,” “expects,” “intends,” “plans,” “believes,” “seeks” and “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements involveare not guarantees of future performance and are subject to risks, uncertainties and other factors, that maysome of which are beyond our control and difficult to predict and could cause our actual results performance or achievements to bediffer materially different from any future results, performance or achievementsthose expressed or implied byforecasted in the forward-looking statements. You should not place undue reliance on these forward-looking statements, and we can give no assurance that our plans, objectives, expectations and prospects will be achieved. which apply only as of the date of this Form 10-Q. Investors should carefully consider all of such risks before making an investment decision with respect to the Company’s stock. The following discussion of our results of operationsand analysis should be read togetherin conjunction with our consolidated financial statements and related notes included elsewhere in this report.summary of selected financial data for Kange Corp. Such discussion represents only the best present assessment from our Management.   GeneralCompany Overview   The Company wasKange Corp., a startupNevada corporation (the “Company,” “Kange,” “we,” and “us”), is a development stage company that was incorporated in Nevada on August 16, 2013.   The Company is developing and marketing a software product as a mobile application for end users of the current generation iPhone and iPad from Apple, Inc., and mobile phones using the Android platform. The mobile application's digital content will be customizable by the owner of the particular device using our software. We plan to stay on the cutting edge of the constantly changing mobile application market, and our goal is to create a quality reputation within the mobile software community and marketplace. We plan to sell our initial applications through Apple's App Store or through our own online retail website to small business owners, who desire their own mobile applications and want to control the content. Apple, App Store, iPhone and iPad are trademarks of Apple Inc., and Android and Google Play are trademarksis a trademark of Alphabet Inc.   On June 8, 2015, the Company entered into a development contract with Idap Group, LTD, a Ukrainian company ("Software Developer"). Under the terms of the contract, Software Developer agreed to provide mobile (pda and smartphone) application ("App") software development to the Company, in exchange for not more than one hundred thousand U.S. dollars. Delivery of the ready software shall be performed by placing it in the App Store and Google Play by Software Developer or transmitted via the Internet.  As of the date of this report, the contract is still in effect.    On November 9, 2015, AMJ Global, LLC ("AMJ Global"), a company beneficially owned by Dr. Arthur Malone, Jr., the Company's chief executive officer and director, assigned the rights of AMJ Global pursuant to its agreements with Blabeey, Inc. ("Blabeey"), a mobile App designer. The irrevocable assignment, transferred and conveyed in its entirety to the Company in a common control transaction, all of AMJ Global's rights and obligations that are stipulated and set forth in every and all agreements between AMJ Global and Blabeey, including, but not limited to, the agreement between AMJ Global and Blabeey dated October 26, 2015. Blabeey's web site is www.blabeey.com, andwhich is not incorporated in this filing. The Company issued 5,000,000 shares of common stock to AMJ Global for the assignment. The Company valued those shares at $471,672, the historical asset costcosts of Blabeey. Subsequently, the Company began working with Blabeey on developing technology for social media regarding Autism, PTSD and other neurological issues.     In May of 2017, the Company retained Bruce Weitzberg to serve on the Company’s Board of Advisors and advise the Company regarding the intersection of technology and wholistic health care treatment and healthy living. Mr. Weitzberg is the CEO of Patient Access Solutions Inc., a Nevada corporation with ticker symbol “PASO” (“PASO”).  PASO is a provider of healthcare and financial processing solutions for the healthcare and dental industries, and it has also opened a new center for the treatment of individuals with autism spectrum disorder and other biomedical conditions.  3 Table of Contents Subsequently, the Company retained James Lantiegne, a professional magician and former COO and CFO of a national software company, to serve on the Company’s Board of Advisors and provide the Company advice on the intersection of technology and health. In October of 2017, the Company retained Benny Malone, former NFL running back for the Miami Dolphins and Washington Redskins, and Eric Metcalf, former NFL running back, wide receiver and three-time Pro-Bowl selection, to serve on the Company’s Board of Advisors and advise the Company regarding sports health issues and treatments.    On November 1, 2017, the Company executed a stock purchase agreement (the “SPA”) with AMJ Global Entertainment, LLC, another related party company controlled by our CEO and director, Dr. Arthur Malone, Jr., to purchase 1,157,142 shares of Patient Access Solutions Inc., a Nevada corporation with ticker symbol “PASO” (“PASO”), in consideration of the issuance of 158,824 shares of our common stock.  PASO is a provider of healthcare and financial processing solutions for the healthcare and dental industries, and it has also opened a new center for the treatment of individuals with autism spectrum disorder and other biomedical conditions. The Company is currently advising PASO on formulating a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s.  The Company is currently evaluating wholistic technology-based healthcare treatments, and is evaluating potential additional operations in the wholistic health industry.  On January 13, 2020, the transaction was rescinded, and the Company will return 1,157,142 shares of Patient Access Solutions Inc. back to AMJ Global Entertainment, LLC in exchange for 157,142 shares of the Company. We have had limited operations and have been issued a "going concern" opinion by our auditor, for the period ended November 30, 2016, based upon our reliance on related party loans and the sale of our common stock as the sole sourcesources of funds for our operations for the near future. Reports to Security Holders The Company is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, and is a “voluntary filer.”  As a voluntary filer, the Company intends to furnish its stockholders with annual reports containing consolidated financial statements audited by its independent registered public accounting firm and to make available quarterly reports containing unaudited consolidated financial statements for each of the first three quarters of each year, but is not obligated to do so. The Company files Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K with the Securities and Exchange Commission. The Company may also file additional documents with the Commission if those documents become necessary in the course of its operations. The public may read and copy any materials that the Company files with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The site address is www.sec.gov. Available Information All reports of the Company filed with the SEC are available free of charge through the SEC’s website at www.sec.gov. In addition, the public may read and copy materials filed by the Company at the SEC’s Public Reference Room located at 100 F Street, N.E., Washington, D.C. 20549. The public may also obtain additional information on the operation of the Public Reference Room by calling the Commission at 1-800-SEC-0330. Results of Operations The following Management Discussiondiscussion and Analysisanalysis of our financial condition and results of operations should be read in conjunction with the unaudited financial statements and accompanying notes included in this Form 10-Q. 12 Table of Contents Results of Operations Three Month Period Ended August 31, 2017 Compared to the Three Month Period Ended August 31, 2016. We recognized no revenuethereto for the three months ended August 31,February 28, 2018 and 2017, and 2016related management discussion herein. Our financial statements are stated in U.S. Dollars and are prepared in accordance with generally accepted accounting principles of the United States (“GAAP”).  4 Table of Contents Going Concern Qualification Several conditions and events cast substantial doubt about the Company’s ability to continue as wea going concern. The Company has incurred cumulative net losses of $704,797 since its inception and requires capital for its contemplated operational and marketing activities to take place. The Company’s ability to raise additional capital through debt or future issuances of capital stock is unknown. The obtainment of additional financing, the successful development of the Company’s contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raise substantial doubt about the Company’s ability to continue as a development stage company.going concern.   DuringFor the Three Months Ended February 28, 2018 and 2017: Our operating results for the three months ended August 31,February 28, 2018 and 2017, we incurred general and administrativethe changes between those periods for the respective items are summarized as follows:     Three Months Ended               February 28,       Change         2018       2017       Amount   Operating loss   $ 29,400     $ 8,009     $ 21,391   Other income (expense)     32,863       (3,177 )     36,040   Net income (loss)   $ 3,463     $ (11,186 )   $ 14,649   Revenues We did not earn any revenues during the three months ending February 28, 2018 or 2017. Operating Income (Loss) Our loss from operations increased to $29,400 during the three months ending February 28, 2018, from an operating loss of $8,009 in the comparative period ending February 28, 2017. The following table presents operating expenses of $2,049 compared to $6,140 incurredfor the three-month periods ending February 28, 2018 and 2017:     Three Months Ended                       February 28,     Change         2018       2017       Amount       Percentage   Consulting Fees     20,712       —       20,712       —   General and administrative expenses     8,688       8,009       679       8 % Total Operating Expenses   $ 29,400     $ 8,009     $ 21,391       267 % The Company recorded $20,712 in consulting fees during the three months ended August 31, 2016. These expenses related to corporate overhead, financial and administrative contracted services. The variance is due to timing of services rendered in connection with the Company's filings. During the three months ended August 31, 2017, we incurred consulting expenses of $76,000February 28, 2018, as compared to $0 incurredfor the same period in the prior fiscal year, due to signed advisory board agreements. We realized an increase of $679 in general and administrative expenses during the three months ended August 31, 2016. The expense was relatedFebruary 28, 2018, as compared to the issuance of stock pursuant to advisory board agreements with four individuals.same period in the prior fiscal year. Our net loss Other Income (Expense) The following table presents other income and expenses for the three months ended February 28, 2018 and 2017: 5 Table of Contents     Three Months Ended       February 28,         2018       2017   Unrealized Gain on investment     32,863       —   Interest expense     —       (1,627 ) Amortization of debt discounts     —       (1,550 ) Total other income (expense)   $ 32,863     $ (3,177 ) During the three months ending February 28, 2018 the Company recognized an unrealized gain on investment of $32,863 due to revaluation of marketable securities. For the same period in the prior fiscal year, the Company recorded interest expense of $1,627, and amortization of debt discounts of $1,550. Net Income (Loss) of the Company realized $3,463 in net income during the three months ended August 31, 2017 was $79,691 comparedFebruary 28, 2018, compare to a net loss of $23,116$11,186 in the same period in the prior fiscal year.  This is due to the net effect of the consulting fees and unrealized gain on marketable securities recognized during the 2018 period. Liquidity and Capital Resources Based upon our current financial condition, we do not have sufficient cash to operate our business at the current level for the next twelve months. We intend to fund operations through debt and/or equity financing arrangements, which may be insufficient to fund expenditures or other cash requirements. We plan to seek additional financing in a private equity offering to secure funding for operations. There can be no assurance that we will be successful in raising additional funding. If we are not able to secure additional funding, the implementation of our business plan will be impaired. There can be no assurance that such additional financing will be available to us on acceptable terms or at all. Working Capital The following table presents our working capital position as of February 28, 2018 and November 30, 2017:       As of       As of                         February 28,       November 30,     Change         2018       2017       Amount       Percentage   Cash   $ —     $ 77     $ (77 )     —   Marketable securities     113,863       81,000       32,863       41 % Prepaid expenses     45,600       66,312       (20,712 )     (31% ) Current Assets     159,463       147,389       12,074       8 % Current Liabilities     41,762       33,151       8,611       26 % Working Capital   $ 117,701     $ 114,238     $ 3,463       3 % The change in working capital during the three months ended February 28, 2018, was primarily due to an increase in current assets of $12,074 and an increase in current liabilities of $8,611. Current assets increased primarily due to revaluation of investment in marketable securities. Current liabilities increased due to an increase in advances from related parties of $1,250, increase in accounts payable of $4,361, and increase in accrued expenses due to related party of $3,000. Cash reduced as of February 28, 2018, by $77 to $0, caused by bank charges during the three months ending February 28, 2018. Cash Flow We fund our operations with cash received from advances from officers and related parties and issuances of equity. 6 Table of Contents The following tables presents our cash flow for the three months period ended August 31, 2016 due to the factors discussed above, including $15,348 of amortization of debt discount for 2016.February 28, 2018 and 2017: Nine Month Period Ended August 31, 2017 Compared to the Nine Month Period Ended August 31,, 2016.     Three Months Ended     February 28,       2018       2017   Cash (used in) operating activities   $ (1,327 )   $ (90 ) Cash provided by financing activities     1,250       —   Net Change in Cash for the period   $ (77 )   $ (90 ) We recognized no revenue for the nine months ended August 31, 2017 and 2016 as we are a development stage company. During the nine months ended August 31, 2017, we incurred general and administrative expenses of $16,629 compared to $23,503 incurred during the nine months ended August 31, 2016. These expenses related to corporate overhead, financial and administrative contracted services. The variance is due to timing of services rendered in connection with the Company's filings. During the nine months ended August 31, 2017, we incurred consulting expenses of $76,000 compared to $0 incurred during the nine months ended August 31, 2016. The expense was related to the issuance of stock pursuant to advisory board agreements with four individuals. Our net loss for the nine months period ended August 31, 2017 was $99,695 compared to a net loss of $70,067 for the nine months period ended August 31, 2016 due to the factors discussed above, including $2,170 of amortization of debt discount for 2017. Liquidity and Capital Resources As of August 31, 2017, our total assets were $77, comprising exclusively of cash, compared to $155 in total assets, also comprising exclusively of cash, at November 30, 2016. As of August 31, 2017, our total liabilities were $92,177, which included accounts payable, accrued expenses, and notes payable to related parties, compared to $68,560 in total liabilities, which included accounts payable, accrued expenses, and notes payable to related parties, at November 30, 2016. Stockholders' deficit was $92,100 as of August 31, 2017 compared to stockholders' deficit of $68,405 as of November 30, 2016. The variance between August 31, 2017 and November 30, 2016 principally relates to operating losses incurred in the period. 13 Table of Contents Cash Flows from Operating Activities NetWe did not generate positive cash flows from operating activities for the three months ended February 28, 2018 or 2017. For the three months ended February 28, 2018, net cash flows used in operating activities was $11,747consisted of a net income of $3,463, reduced by unrealized gain on marketable securities of $32,863, and $32,436increased by a net increase in change of operating assets and liabilities of $28,073.  For the ninethree months ended August 31,February 28, 2017, net cash flows used in operating activities consisted of a net loss of $11,186, increased by amortization of debt discounts of $1,550 and 2016, respectively. The decrease was primarily due to the increasenet change in payablesoperating assets and accrued expenses between the two periods.liabilities of $9,546. Cash Flows from Investing Activities The Company has not generated or used any cash flows from investing activities duringFor the ninethree months ended August 31,February 28, 2018 and 2017, and 2016.no cashflows were used in investing activities. Cash Flows from Financing Activities For the three months ended February 28, 2018, we received $1,250 advance from related parties, which used to fund operations and business activities.  We didn’t engage in financing activities during the three months ended February 28, 2017.   We have historically financed our operations primarily from either advances from our shareholder or the issuance of equity. We received $11,669 and $32,438 in advances from our shareholder and issuance of convertible note to related parties during the nine months ended August 31, 2017 and 2016, respectively.Off-Balance Sheet Arrangements   Going Concern The accompanying unaudited condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company sustained net losses of $99,695 and used cash in operating activities of $11,747 for the nine months ended August 31, 2017. The Company had working capital deficit, stockholders' deficit and accumulated deficit of $92,100, $92,100 and $719,923, respectively, at August 31, 2017. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital and loans from third parties to sustain its current level of operations. The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships. No assurance can be given that the Company will be successful in these efforts. Plan of Operation and Funding We expect that working capital requirements will continue to be funded through a combination of loans from our director and further issuances of securities. Our working capital requirements are expected to increase in line with the growth of our business. Off-Balance Sheet Arrangements As of the date of this Quarterly Report, we dodoes not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on ourthe Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.   147 Table of Contents   Critical Accounting Policies The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Such estimates and assumptions affect the reported amounts of revenues and expenses during the reporting period. We base our estimates on historical experiences and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions and conditions. We continue to monitor significant estimates made during the preparation of our financial statements. On an ongoing basis, we evaluate estimates and assumptions based upon historical experience and various other factors and circumstances. We believe our estimates and assumptions are reasonable in the circumstances; however, actual results may differ from these estimates under different future conditions. See Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" and Note 2, "Summary of Significant Accounting Policies" in our audited financial statements for the year ended November 30, 2016, included in our Annual Report on Form 10-K as filed on March 3, 2017, for a discussion of our critical accounting policies and estimates. ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKRISK.   As a "smaller reporting company" as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.Not Applicable.   ITEM 4. CONTROLS AND PROCEDURES PROCEDURES.   Evaluation of Disclosure Controls and Procedures   The Securities and Exchange Commission defines the term "disclosure“disclosure controls and procedures"procedures” to mean a company'sthe company’s controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission'sCommission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer'sissuer’s management, including its chiefprincipal executive and chiefprincipal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a simple system of controls and procedures in an effort to ensure that all information which it is required to disclose in the reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified under the SEC'sSEC’s rules and forms and that information required to be disclosed is accumulated and communicated to the chiefprincipal executive and interim chiefprincipal financial officerofficers to allow timely decisions regarding disclosure.   As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officerchief executive officer and Chief Financial Officer,chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, the Chief Executive Officerour chief executive officer and Chief Financial Officer havechief financial officer concluded that the Company'sour disclosure controls and procedures arewere not effective to provide reasonable assurance of achieving the objectives of timely alerting them to material information required to be included in our periodic SEC reports and of ensuring that such information is recorded, processed, summarized and reported with the time periods specified. Our chief executive officer and chief financial officer also concluded that our disclosure controls and procedures were not effective as of such date. The Chief Executive Officer and Chief Financial Officer have determined that the Company continuesend of the period covered by this report to haveprovide reasonable assurance of the following deficiencies which represent a material weakness:achievement of these objectives.   1. The Company intends to appoint additional independent directors; 2. Lack of in-house personnel with the technical knowledge to identify and address some of the reporting issues surrounding certain complex or non-routine transactions. With material, complex and non-routine transactions, management has and will continue to seek guidance from third-party experts and/or consultants to gain a thorough understanding of these transactions; 3. Insufficient personnel resources within the accounting function to segregate the duties over financial transaction processing and reporting; 4. Insufficient written policies and procedures over accounting transaction processing and period end financial disclosure and reporting processes. 15 Table of Contents To remediate our internal control weaknesses, management intends to implement the following measures: · The Company will add sufficient number of independent directors to the board and appoint additional member(s) to the Audit Committee. · The Company will add sufficient accounting personnel to properly segregate duties and to effect a timely, accurate preparation of the financial statements. · The Company will hire staff technically proficient at applying U.S. GAAP to financial transactions and reporting. · Upon the hiring of additional accounting personnel, the Company will develop and maintain adequate written accounting policies and procedures. The additional hiring is contingent upon The Company's efforts to obtain additional funding through equity or debt and the results of its operations. Management expects to secure funds in the coming fiscal year but provides no assurances that it will be able to do so. Changes in Internal Control over Financial Reporting   There waswere no changechanges in the Company'sCompany’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or 15d-15 of the Exchange Act that occurred during the periodquarter ended August 31, 2017,February 28, 2018, that hashave materially affected, or isare reasonably likely to materially affect, the Company'sCompany’s internal control over financial reporting. Limitations on the Effectiveness of Controls The Company's management, including the CEO and CFO, does not expect that our disclosure controls and procedures or our internal control over financial reporting, when implemented, will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met. Further, the design of the control system must reflect that there are resource constraints and that the benefits must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.   168 Table of Contents PART II - OTHER INFORMATION   ITEM 1. LEGAL PROCEEDINGS PROCEEDINGS.   ManagementThe Company is not aware ofa party to any significant pending legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this Quarterly Report,than as disclosed below, and no other such proceedings are known to be contemplated. No director, officer or affiliate of the Company, and no owner of record or beneficial owner of more than 5.0% of the securities of the Company, or any associate of any such director, officer or security holder is (i) a party adverse to usthe Company or has a material interest adverse to the Company in any legal proceeding, or (ii) has an adverse interestreference to us in any legal proceedings. Management is not aware of any other legal proceedings pending or that have been threatened against us or our properties.litigation.   ITEM 1A. RISK FACTORS. Not applicable. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDSPROCEEDS. None.   There were no unregistered sales of equity securities during the quarterly period ending August 31, 2017. ITEM 3. DEFAULTS UPON SENIOR SECURITIESSECURITIES. None.   We have no senior securities outstanding in any of the periods presented in these financial statements. ITEM 4. MINE SAFETY DISCLOSURESDISCLOSURES. None.   Not applicable to our Company. ITEM 5. OTHER INFORMATIONINFORMATION. None.   None. ITEM 6. EXHIBITS.   Exhibit Description   17 3.1   Table of Contents ITEM 6. EXHIBITS See the Exhibit Index following the signature page of this Registration Statement, which Exhibit Index is incorporated herein by reference. Number Description 3.1 Articles of Incorporation (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014) 3.2 BylawsBy laws (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014) 5.110.1 Opinion re: Legality and Consent of Counsel (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014) 10.1 Agreement executed by Audit for the Period Ended November 6, 2014 of Kange Corp., the private company (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014) 10.2 Verbal Agreement executed: description of material loan from Mr. Brakin to Kange Corp. (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014) 10.3 Assignment of Rights Agreement between the Company and AMJ Global (incorporated by reference to our Current Report on Form 8-K filed on November 12, 2015) 31.1 (1)31.1* Certification of Principal Executive Officer of Kange Corp.CEO required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2 (1)32.1* Certification of Principal Accounting Officer of Kange Corp. required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1 (1) Certification of Principal Executive Officer of Kange Corp.CEO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 Ofof 18 U.S.C. 63 32.2 (1)101.INS** Certification of Principal Accounting Officer of Kange Corp. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 Of 18 U.S.C. 63XBRL Instance Document 101.INS101.SCH** XBRL Taxonomy Extension Instance Document 101.SCH XBRL Taxonomy Extension Schema Document 101.CAL101.CAL** XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF101.DEF** XBRL Taxonomy Extension Definition Linkbase Document 101.LAB101.LAB** XBRL Taxonomy Extension Label Linkbase Document 101.PRE101.PRE** XBRL Taxonomy Extension Presentation Linkbase Document ___________ ___________*   Filed herewith. (1) Filed herewith** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections. 9 18 Table of Contents SIGNATURES   SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.   Kange Corp.KANGE CORP. Dated: October 23, 2017Date: May 10, 2021 By: /s/ Dr. Arthur Malone, Jr. Dr. Arthur Malone, Jr. Chief Executive Officer, and Chief Financial Officer & Director     1910